Published in Nat Biotechnol on November 30, 2003
The 37/67-kilodalton laminin receptor is a receptor for adeno-associated virus serotypes 8, 2, 3, and 9. J Virol (2006) 2.94
Noninvasive biophotonic imaging for studies of infectious disease. FEMS Microbiol Rev (2010) 1.44
Control of mesothelin-expressing ovarian cancer using adoptive transfer of mesothelin peptide-specific CD8+ T cells. Gene Ther (2007) 1.40
Oncolytic virus therapy for glioblastoma multiforme: concepts and candidates. Cancer J (2012) 1.35
Targeting human glioblastoma cells: comparison of nine viruses with oncolytic potential. J Virol (2005) 1.34
Semliki forest virus-induced endoplasmic reticulum stress accelerates apoptotic death of mammalian cells. J Virol (2010) 1.07
Oncolytic virotherapy in veterinary medicine: current status and future prospects for canine patients. J Transl Med (2012) 1.01
Enhanced specific delivery and targeting of oncolytic Sindbis viral vectors by modulating vascular leakiness in tumor. Cancer Gene Ther (2009) 1.00
Antigen-specific immunotherapy of cervical and ovarian cancer. Immunol Rev (2008) 0.96
Oncolytic Sindbis virus targets tumors defective in the interferon response and induces significant bystander antitumor immunity in vivo. Mol Ther (2011) 0.94
Sindbis viral vector induced apoptosis requires translational inhibition and signaling through Mcl-1 and Bak. Mol Cancer (2010) 0.93
Structure-guided identification of a laminin binding site on the laminin receptor precursor. J Mol Biol (2010) 0.87
Identification and characterization of alphavirus M1 as a selective oncolytic virus targeting ZAP-defective human cancers. Proc Natl Acad Sci U S A (2014) 0.87
Cancer immunotherapy using irradiated tumor cells secreting heat shock protein 70. Cancer Res (2007) 0.87
Vesicular stomatitis virus modified with single chain IL-23 exhibits oncolytic activity against tumor cells in vitro and in vivo. Int J Interferon Cytokine Mediat Res (2010) 0.84
Directed evolution of a virus exclusively utilizing human epidermal growth factor receptor as the entry receptor. J Virol (2013) 0.84
Virotherapy, gene transfer and immunostimulatory monoclonal antibodies. Oncoimmunology (2012) 0.83
Delivery of chemotherapeutic agents using drug-loaded irradiated tumor cells to treat murine ovarian tumors. J Biomed Sci (2010) 0.83
Translation control by protein kinase R restricts minute virus of mice infection: role in parvovirus oncolysis. J Virol (2010) 0.83
Activation of cytotoxic and regulatory functions of NK cells by Sindbis viral vectors. PLoS One (2011) 0.83
Sindbis virus replication, is insensitive to rapamycin and torin1, and suppresses Akt/mTOR pathway late during infection in HEK cells. Biochem Biophys Res Commun (2011) 0.81
Alphaviruses in gene therapy. Viruses (2015) 0.79
Gene-enhanced tissue engineering for dental hard tissue regeneration: (1) overview and practical considerations. Head Face Med (2006) 0.79
Sindbis viral vectors transiently deliver tumor-associated antigens to lymph nodes and elicit diversified antitumor CD8+ T-cell immunity. Mol Ther (2013) 0.79
Alphaviruses in gene therapy. Viruses (2009) 0.78
Replicase-based plasmid DNA shows anti-tumor activity. BMC Cancer (2011) 0.78
Imaging early steps of sindbis virus infection by total internal reflection fluorescence microscopy. Adv Virol (2011) 0.77
Oncolytic activity of Sindbis virus in human oral squamous carcinoma cells. Br J Cancer (2009) 0.76
Tumor-specific targeting with modified Sindbis viral vectors: evaluation with optical imaging and positron emission tomography in vivo. Mol Imaging Biol (2013) 0.76
Oncolytic viral therapy for neuroblastoma cells with Sindbis virus AR339 strain. Pediatr Surg Int (2015) 0.76
Lipopolysaccharide inhibits Sindbis virus-induced IP-10 release in human peripheral blood mononuclear cells. Viral Immunol (2011) 0.75
ATM kinase is activated by sindbis viral vector infection. Virus Res (2012) 0.75
Control of the rescue and replication of Semliki Forest virus recombinants by the insertion of miRNA target sequences. PLoS One (2013) 0.75
Viral Inhibition of the IFN-Induced JAK/STAT Signalling Pathway: Development of Live Attenuated Vaccines by Mutation of Viral-Encoded IFN-Antagonists. Vaccines (Basel) (2016) 0.75
Replicon RNA Viral Vectors as Vaccines. Vaccines (Basel) (2016) 0.75
Oncolytic Alphaviruses in Cancer Immunotherapy. Vaccines (Basel) (2017) 0.75
Senescence of activated stellate cells limits liver fibrosis. Cell (2008) 8.98
Accessory gene regulator (agr) locus in geographically diverse Staphylococcus aureus isolates with reduced susceptibility to vancomycin. Antimicrob Agents Chemother (2002) 4.83
Novel cassette-based shuttle vector system for gram-positive bacteria. Appl Environ Microbiol (2004) 3.97
Phospholipase Cgamma activates Ras on the Golgi apparatus by means of RasGRP1. Nature (2003) 3.66
Adaptive Foxp3+ regulatory T cell-dependent and -independent control of allergic inflammation. Immunity (2008) 3.33
Distinguishing human ethnic groups by means of sequences from Helicobacter pylori: lessons from Ladakh. Proc Natl Acad Sci U S A (2004) 2.83
Identification of a therapeutic strategy targeting amplified FGF19 in liver cancer by Oncogenomic screening. Cancer Cell (2011) 2.56
Detrimental ventricular remodeling in patients with congenital complete heart block and chronic right ventricular apical pacing. Circulation (2004) 2.50
A hypoxia-controlled cap-dependent to cap-independent translation switch in breast cancer. Mol Cell (2007) 2.44
Staphylococcus aureus accessory gene regulator (agr) group II: is there a relationship to the development of intermediate-level glycopeptide resistance? J Infect Dis (2003) 2.44
Antibiotic-induced SOS response promotes horizontal dissemination of pathogenicity island-encoded virulence factors in staphylococci. Mol Microbiol (2005) 2.42
Reduced susceptibility of Staphylococcus aureus to vancomycin and platelet microbicidal protein correlates with defective autolysis and loss of accessory gene regulator (agr) function. Antimicrob Agents Chemother (2005) 2.34
agr function in clinical Staphylococcus aureus isolates. Microbiology (2008) 2.33
Intravital observation of Plasmodium berghei sporozoite infection of the liver. PLoS Biol (2005) 2.32
Regeneration of hepatocyte 'buds' in cirrhosis from intrabiliary stem cells. J Hepatol (2003) 2.31
Transient interference with staphylococcal quorum sensing blocks abscess formation. Proc Natl Acad Sci U S A (2005) 2.30
Prevalence of agr dysfunction among colonizing Staphylococcus aureus strains. J Infect Dis (2008) 2.29
Hypoxia-inducible factor 1 and VEGF upregulate CXCR4 in glioblastoma: implications for angiogenesis and glioma cell invasion. Lab Invest (2006) 2.14
beta-lactam antibiotics induce the SOS response and horizontal transfer of virulence factors in Staphylococcus aureus. J Bacteriol (2006) 2.07
Peptide signaling in Staphylococcus aureus and other Gram-positive bacteria. Peptides (2004) 2.05
Phage-mediated intergeneric transfer of toxin genes. Science (2009) 2.01
Effect of mild acid on gene expression in Staphylococcus aureus. J Bacteriol (2004) 1.96
CCR7 signalling as an essential regulator of CNS infiltration in T-cell leukaemia. Nature (2009) 1.94
Synthesis of group A streptococcal virulence factors is controlled by a regulatory RNA molecule. Mol Microbiol (2004) 1.92
Inhibition of rot translation by RNAIII, a key feature of agr function. Mol Microbiol (2006) 1.90
Mechanical load initiates hypertrophic scar formation through decreased cellular apoptosis. FASEB J (2007) 1.87
Key determinants of receptor activation in the agr autoinducing peptides of Staphylococcus aureus. Biochemistry (2002) 1.84
Down-regulation of diabetogenic CD4+ T cells by a soluble dimeric peptide-MHC class II chimera. Nat Immunol (2002) 1.81
SaPI mutations affecting replication and transfer and enabling autonomous replication in the absence of helper phage. Mol Microbiol (2007) 1.80
Adenosine A(2A) receptors play a role in the pathogenesis of hepatic cirrhosis. Br J Pharmacol (2006) 1.79
Uroplakins in urothelial biology, function, and disease. Kidney Int (2009) 1.79
High genetic variability of the agr locus in Staphylococcus species. J Bacteriol (2002) 1.78
Stromal cell-derived factor-1alpha and CXCR4 expression in hemangioblastoma and clear cell-renal cell carcinoma: von Hippel-Lindau loss-of-function induces expression of a ligand and its receptor. Cancer Res (2005) 1.68
Ras activation in Jurkat T cells following low-grade stimulation of the T-cell receptor is specific to N-Ras and occurs only on the Golgi apparatus. Mol Cell Biol (2004) 1.66
SaPI operon I is required for SaPI packaging and is controlled by LexA. Mol Microbiol (2007) 1.65
Source control in the management of severe sepsis and septic shock: an evidence-based review. Crit Care Med (2004) 1.65
Staphylococcus aureus leucocidin ED contributes to systemic infection by targeting neutrophils and promoting bacterial growth in vivo. Mol Microbiol (2011) 1.64
Moonlighting bacteriophage proteins derepress staphylococcal pathogenicity islands. Nature (2010) 1.64
Killing niche competitors by remote-control bacteriophage induction. Proc Natl Acad Sci U S A (2009) 1.57
Staphylococcus aureus pathogenicity island DNA is packaged in particles composed of phage proteins. J Bacteriol (2008) 1.57
Global repression of exotoxin synthesis by staphylococcal superantigens. Proc Natl Acad Sci U S A (2002) 1.57
Responses of endoscopy patients in Ladakh, India, to Helicobacter pylori whole-cell and Cag A antigens. Clin Diagn Lab Immunol (2002) 1.55
The agr radiation: an early event in the evolution of staphylococci. J Bacteriol (2005) 1.55
Adenosine promotes wound healing and mediates angiogenesis in response to tissue injury via occupancy of A(2A) receptors. Am J Pathol (2002) 1.50
Adaptation of Staphylococcus aureus to ruminant and equine hosts involves SaPI-carried variants of von Willebrand factor-binding protein. Mol Microbiol (2010) 1.49
Hypoxia- and vascular endothelial growth factor-induced stromal cell-derived factor-1alpha/CXCR4 expression in glioblastomas: one plausible explanation of Scherer's structures. Am J Pathol (2008) 1.48
Regulatory organization of the staphylococcal sae locus. Microbiology (2008) 1.47
Transmembrane topology of AgrB, the protein involved in the post-translational modification of AgrD in Staphylococcus aureus. J Biol Chem (2002) 1.39
Cyclic peptide inhibitors of staphylococcal virulence prepared by Fmoc-based thiolactone peptide synthesis. J Am Chem Soc (2008) 1.39
Adenosine signaling contributes to ethanol-induced fatty liver in mice. J Clin Invest (2009) 1.38
A pathogenicity island replicon in Staphylococcus aureus replicates as an unstable plasmid. Proc Natl Acad Sci U S A (2007) 1.37
Role of staphylococcal phage and SaPI integrase in intra- and interspecies SaPI transfer. J Bacteriol (2007) 1.37
Intratumoral spread of wild-type adenovirus is limited after local injection of human xenograft tumors: virus persists and spreads systemically at late time points. Hum Gene Ther (2003) 1.35
Staphylococcal pathogenicity island interference with helper phage reproduction is a paradigm of molecular parasitism. Proc Natl Acad Sci U S A (2012) 1.35
LEF1 in androgen-independent prostate cancer: regulation of androgen receptor expression, prostate cancer growth, and invasion. Cancer Res (2009) 1.34
Adenosine A(2A) receptor activation promotes wound neovascularization by stimulating angiogenesis and vasculogenesis. Am J Pathol (2004) 1.33
Hydrophobic interactions drive ligand-receptor recognition for activation and inhibition of staphylococcal quorum sensing. Proc Natl Acad Sci U S A (2004) 1.31
Differences on the inhibitory specificities of H-Ras, K-Ras, and N-Ras (N17) dominant negative mutants are related to their membrane microlocalization. J Biol Chem (2002) 1.31
Comparison of five antibodies as markers in the diagnosis of melanoma in cytologic preparations. Am J Clin Pathol (2002) 1.30
Ecto-5'-nucleotidase (CD73) -mediated extracellular adenosine production plays a critical role in hepatic fibrosis. FASEB J (2008) 1.28
Reversible and specific extracellular antagonism of receptor-histidine kinase signaling. J Biol Chem (2001) 1.28
Mutations in agr do not persist in natural populations of methicillin-resistant Staphylococcus aureus. J Infect Dis (2010) 1.27
Specificity of staphylococcal phage and SaPI DNA packaging as revealed by integrase and terminase mutations. Mol Microbiol (2009) 1.27
agr receptor mutants reveal distinct modes of inhibition by staphylococcal autoinducing peptides. Proc Natl Acad Sci U S A (2009) 1.23
Identification of ligand specificity determinants in AgrC, the Staphylococcus aureus quorum-sensing receptor. J Biol Chem (2008) 1.23
The N-ras proto-oncogene can suppress the malignant phenotype in the presence or absence of its oncogene. Cancer Res (2002) 1.23
Retroperitoneal perforation of the duodenum from biliary stent erosion. Curr Surg (2005) 1.23
Downregulation of major histocompatibility complex antigens in invading glioma cells: stealth invasion of the brain. Lab Invest (2005) 1.22
A phase II trial of sorafenib in metastatic melanoma with tissue correlates. PLoS One (2010) 1.17
Fra-2/AP-1 controls bone formation by regulating osteoblast differentiation and collagen production. J Cell Biol (2010) 1.16
Overexpression of epidermal growth factor receptor in urothelium elicits urothelial hyperplasia and promotes bladder tumor growth. Cancer Res (2002) 1.16
CD40 contributes to lethality in acute sepsis: in vivo role for CD40 in innate immunity. Infect Immun (2003) 1.15
Ethnic differences in expression of the dysregulated proteins in uterine leiomyomata. Hum Reprod (2005) 1.15
Tumor-specific in vivo transfection with HSV-1 thymidine kinase gene using a Sindbis viral vector as a basis for prodrug ganciclovir activation and PET. J Nucl Med (2006) 1.15
Endothelial nitric oxide synthase (eNOS) knockout mice have defective mitochondrial beta-oxidation. Diabetes (2007) 1.14
A nonsense mutation in agrA accounts for the defect in agr expression and the avirulence of Staphylococcus aureus 8325-4 traP::kan. Infect Immun (2007) 1.14
Alterations in the expression of PDCD4 in ductal carcinoma of the breast. Oncol Rep (2007) 1.12
Regulation of HMGA1 expression by microRNA-296 affects prostate cancer growth and invasion. Clin Cancer Res (2010) 1.11
Racial disparity of epidermal growth factor receptor expression in prostate cancer. J Clin Oncol (2004) 1.10
Sequence analysis reveals genetic exchanges and intraspecific spread of SaPI2, a pathogenicity island involved in menstrual toxic shock. Microbiology (2007) 1.10
Using sindbis viral vectors for specific detection and suppression of advanced ovarian cancer in animal models. Cancer Res (2004) 1.09
Mice deficient for N-ras: impaired antiviral immune response and T-cell function. Cancer Res (2003) 1.07
Circulating Bmi-1 mRNA as a possible prognostic factor for advanced breast cancer patients. Breast Cancer Res (2007) 1.07
Fascin-1 expression in papillary and invasive urothelial carcinomas of the urinary bladder. Hum Pathol (2005) 1.07
Exoerythrocytic development of Plasmodium gallinaceum in the White Leghorn chicken. Int J Parasitol (2007) 1.04
Multiple functions of the 37/67-kd laminin receptor make it a suitable target for novel cancer gene therapy. Mol Ther (2009) 1.03
Staphylococcal pathogenicity island DNA packaging system involving cos-site packaging and phage-encoded HNH endonucleases. Proc Natl Acad Sci U S A (2014) 1.03
Origin of the tetraspanin uroplakins and their co-evolution with associated proteins: implications for uroplakin structure and function. Mol Phylogenet Evol (2006) 1.02
Preneoplastic lesions of the lung. Respir Res (2002) 1.01
Inhibition of Ras oncogenic activity by Ras protooncogenes. Int J Cancer (2005) 1.01